Use of irinotecan for treatment of resistant breast cancer

Details Use of irinotecan for treatment of resistant breast cancer Use of irinotecan for treatment of resistant breast cancer

A - Human Necessities

61

K

A61K 31/4745 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2523152

The present invention relates to a method for treating locally advanced or metastatic breast cancer in a patient who demonstrated failure of prior treatment with an anthracycline, a taxane and a fluoropyrimidine, which comprises administering a therapeutically effective amount of irinotecan.

La présente invention concerne une méthode pour traiter des cancers du sein métastatiques ou à un stade localement avancé chez un patient ayant révélé l'échec d'un traitement préalable avec une anthracycline, un taxane et une fluoropyrimédine. Cette méthode consiste à administrer audit patient une quantité thérapeutiquement efficace d'irinotécan.

Affiliated with

Also associated with

Rating

Use of irinotecan for treatment of resistant breast cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of irinotecan for treatment of resistant breast cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of irinotecan for treatment of resistant breast cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1891355